SUI Group Holdings Ltd美股招股说明书(2025-09-09版)

高达9,402,675,550股普通股由卖方股东发售 This prospectus covers the offer and potential resale by certain selling stockholders identified herein (“Selling Stockholders”) of (i) 75,881,625 shares of common stock of Sui Group Holdings Limited (“we,” “us,” “our,” the “Company” or “SUIG”), par value $0.001 per share (the “Common Stock”), (ii) 7,144,205 shares of our common stock issuable upon the exercise of pre-funded warrants (“Pre-Funded Warrant Shares”) at an exercise price of $0.0001 per Pre-Funded Warrant Share, (iii) 3,113,469 shares of our common stock issuable to Karatage Opportunities upon the exercise of warrants (the “Lead Investor Warrant Shares”) at various exercise prices per Lead Investor Warrant Share as follows: (a) 1,245,387 Lead Investor Warrant Shares at an exercise price of $5.42 perLead Investor Warrant Share; (b) 1,245,387 Lead Investor Warrant Shares at an exercise price of $5.962 per Lead Investor Warrant Share; (c) 415,130 Lead Investor Warrant Shares at an exercise price of $6.504 per LeadInvestor Warrant Share; and (d) 207,565 Lead Investor Warrant Shares at an exercise price of $7.046 per LeadInvestor Warrant Share, (iv) 3,113,469 shares of our common stock issuable to the Sui Foundation (the “Foundation Investor”) upon the exercise of warrants (the “Foundation Investor Warrant Shares”) at various exercise prices per Foundation Investor Warrant Share as follows: (a) 1,245,387 Foundation Investor Warrant Shares at an exercise price of $5.42 per Foundation Investor Warrant Share; (b) 1,245,387 Foundation Investor Warrant Shares at an exercise price of $5.962 per Foundation Investor Warrant Share; (c) 415,130 Foundation InvestorWarrant Shares at an exercise price of $6.504 per Foundation Investor Warrant Share; and (d) 207,565 Foundation Investor Warrant Shares at an exercise price of $7.046 per Foundation Investor Warrant Share, (v) 1,245,388 shares of our common stock issuable to certain members of the management of the Company upon the exercise of warrants (the “Management Warrant Shares”) at various exercise prices per Management Warrant Share as follows: (a) 622,694 Management Warrant Shares at an exercise price of $5.42 per Management WarrantShares; (b) 415,129 Management Warrant Shares at an exercise price of $6.504 per Management Warrant Share; and (c) 207,565 Management Warrant Shares at an exercise price of $7.046 per Management Warrant Share, (vi) 207,565 shares of common stock issuable to certain advisors of the Company upon the exercise of warrants (the “Advisor Warrants”) at an exercise price of $5.962 per Advisor Warrant Share, (vii) 3,113,469 shares ofcommon stock issuable to A.G.P./Alliance Global Partners (“A.G.P.”) pursuant to the Placement Agency Agreement (the “Placement Agency Agreement”) with A.G.P., dated July 27, 2025 (the “Placement Agent Warrant Shares”) at an exercise price of $5.962 per Placement Agent Warrant Share, and (viii) warrants issuable to DanaWagner, a member of our board of directors, to purchase 207,565 shares of Common Stock (the “Director Warrant Shares”) at various prices per share of Common Stock as follows: (a) 83,026 shares of Common Stock at an exercise price of $5.42 per share of Common Stock; (b) 41,513 shares of Common Stock at an exercise priceof $5.962 per share of Common Stock; (c) 41,513 shares of Common Stock at an exercise price of $6.504 per share of Common Stock; and (d) 41,513 shares of Common Stock at an exercise price of $7.046 per share of Common Stock. The Director Warrants are exercisable for a period of five years. 我们代表卖方股东注册股份，以便他们不时地提供和出售。我们根据本招股说明书不销售任何证券，且不会根据本招股说明书收到卖方股东出售普通股的任何收入。卖方股东可以向我们或通过一家或多家承销商、经销商和代理人提供和出售这些股份，或直接向购买者提供和出售，或通过这些方法的组合或法律允许的任何其他方法。参见“分发计划“关于出售股份股东如何出售或以其他方式处置此类股份的更多信息。我们登记这些股份并不意味着出售股份股东将提供或出售我们任何普通股。” 我们的普通股目前在美国纳斯达克资本市场上市，股票代码为“SUIG”。截至2025年9月8日，我们普通股的最后 reported sale price 为5.94美元。如适用，适用的招股说明书补充文件将包含关于我们普通股上市（如有）或招股说明书所涵盖的任何证券在美国纳斯达克资本市场或任何其他证券市场或证券交易所上市（如有）的信息。 我国证券的潜在购买者被敦促获取有关我国证券市场价格的现行信息，如适用。 根据规则S-K第10(f)(1)条中定义，“小型报告公司”，因此，我们选择遵守某些降低的公众公司报告要求，适用于本招股说明书作为一部分的注册声明以及未来的提交文件。参见招股说明书摘要——成为小型报告公司的启示和“风险因素——与本发行相关及持有我们普通股的风险.” 美国证券交易委员会或任何州证券委员会均未批准或拒绝这些证券，也未对招股说明书的真实性或充分性进行过审查。任何与此相反的表示均构成刑事犯罪。 我们可能会不时通过提交所需的修订或补充来修订或补充本招股说明书。我们敦促您在做出投资决策之前，仔细阅读本招股说明书、任何修订或补充、任何自由书写的招股说明书以及任何经引用的文件。 投资我们的证券涉及高度风险。请参阅本招股说明书第7页开始的“风险因素”，以了解您在投资我们的证券时应考虑的某些风险。 此招股说明书日期为2025年9月8日。 目录 目录 目录 关于此招股说明书 您应当仅依赖本招股说明书或由我们或代表我们编制的任何适用招股说明书补充文件中包含的信息。我们或出售股份持有人均未授权任何人提供本招股说明书、任何随附招股说明书补充文件或我们已编制的任何自由书写招股说明书以外的任何信息或作出任何陈述。我们和出售股份持有人对他人可能向您提供的任何其他信息概不负责，亦不对此类信息的可靠性提供任何保证。本招股说明书仅限于在此处提供的证券的出售要约，并且仅在合法进行此类要约或出售的司法管辖区内有效。任何交易商、销售人员或其他人无权提供本招股说明书、任何适用招股说明书补充文件或任何相关自由书写招股说明书中未包含的任何信息或作出任何陈述。本招股说明书并非证券出售要约，亦非在任何要约或出售被禁止的司法管辖区内进行的证券购买要约邀请。您应当假定本招股说明书或任何招股说明书补充文件中显示的信息，仅在其文件正面的日期为准确，而与本招股说明书或任何适用招股说明书补充文件的交付时间或任何证券的出售时间无关。我们的业务、财务状况、经营成果和前景可能自那些日期以来已经发生变化。 本招股说明书包含某些文件中包含的部分条款的摘要，但完整信息应以实际文件为准。所有摘要均经实际文件整体确认。本说明书中提及的某些文件的副本已被提交、将提交或将以附件形式作为本说明书记录注册声明的一部分被引用，您可以按照“以下标题”部分的说明获取这些文件的副本。在哪里可以找到更多信息.” ii 目录 注意：关于前瞻性声明和行业数据 本招股说